Postdoctoral Research Engineer: Innovative Engineering and Automation for S at Universiteit Leiden
Leiden, , Netherlands -
Full Time


Start Date

Immediate

Expiry Date

14 Nov, 25

Salary

3.546

Posted On

15 Aug, 25

Experience

0 year(s) or above

Remote Job

Yes

Telecommute

Yes

Sponsor Visa

No

Skills

Biomedical Engineering, Systems Engineering, English, Data Analysis, Industrial Applications, Communication Skills, Team Spirit

Industry

Pharmaceuticals

Description

Vacancy number
15912
Job type
Academic staff
Hours (in fte)
1,0
External/ internal
External
Location
Leiden
Placed on
14 August 2025
Closing date
5 September 2025 22 more days to apply
The Metabolomics & Analytics Centre at the Leiden Academic Centre for Drug Research (LACDR) at Leiden University is looking for a:

REQUIREMENTS

  • Highly motivated, enthusiastic, and proactive research engineer with a passion for innovation and strong inter-disciplinary skills;
  • PhD degree in Instrument or Analytical Engineering, Mechanical Engineering, Biomedical Engineering, Systems Engineering or a related engineering field. Industry experience in the domain of engineering is a strong plus;
  • Experience with bio-microfluidics engineering (Computer-Aided Design and micromilling), biosensing and data analysis. Experience with reliability testing and quality control, programming, circuit board design and/or cleanroom manufacturing is a strong plus;
  • Entrepreneurial spirit;
  • Experience with industrial applications of analytical systems with an end user-focused mindset is preferred;
  • Curious and creative in providing tailored solutions;
  • Good team spirit and able to work independently;
  • Good communication skills and able to collaborate with industrial and academic partners;
  • Proficient in spoken and written English.
Responsibilities

You will focus on 1) engineering an automated analyzer platform able to measure metabolites and lipids, but also proteins, in individual cells using high resolution mass spectrometry, 2) developing applications showing the relevance of single cell metabolomics for efficacy of cancer immune therapy and 3) prepare launch of a start-up for this innovative single cell analysis platform.

Loading...